Atlas Trials

A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT

Clinical trial NCT01639261 · UNKNOWN

Trial details

NCT number
NCT01639261
Sponsor
University Hospital Regensburg
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Steroid-refractory Bronchiolitis Obliterans
Start date
2012-07-01
Primary completion
2013-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.